Viewing StudyNCT00039780

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00039780
Status: COMPLETED
Last Update Posted: 2022-07-13
First Post: 2002-06-10
Brief Title: Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
Sponsor: BioNumerik Pharmaceuticals Inc
Organization: BioNumerik Pharmaceuticals Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastases Neoplasm
Breast Neoplasms
Breast Diseases
Keywords:
Name View
Prevention View
Breast View
Cancer View
Metastatic View
Paclitaxel View
Peripheral View
Taxol View
Neuropathy View
Neurotoxicity View
Paresthesias View
Weekly View
BNP7787 View
7787 View
Tavocept View